Edition:
United Kingdom

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

3.83USD
16 Feb 2018
Change (% chg)

$-0.05 (-1.29%)
Prev Close
$3.88
Open
$3.87
Day's High
$3.94
Day's Low
$3.81
Volume
201,000
Avg. Vol
392,477
52-wk High
$7.88
52-wk Low
$3.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.60 -0.125
Jun '17 1.60 -0.131
Mar '17 1.60 -0.150
FY 2016 Dec '16 1.60 -0.113
Sep '16 1.60 -0.111
Jun '16 1.70 -1.006
Mar '16 1.97 -0.092
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 1.27 1.60 0.75 1.46
Quarter Ending Jun-18 3 1.27 1.60 0.75 1.46
Year Ending Dec-18 4 5.45 6.40 3.00 8.49
Earnings (per share)
Quarter Ending Mar-18 3 -0.13 -0.12 -0.14 -0.15
Quarter Ending Jun-18 3 -0.14 -0.13 -0.15 -0.15
Year Ending Dec-18 4 -0.59 -0.54 -0.64 -0.51
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta 1.54 0.90 0.89
Price to Sales (TTM) 139.32 110.72 5.77
Price to Book (MRQ) -- 13.56 5.41
Price to Tangible Book (MRQ) 12.72 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 54.51 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -5.89 398.33 9.24
Sales (TTM) vs TTM 1 Yr. Ago -14.29 78.63 5.59
Sales - 5 Yr. Growth Rate 59.39 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.01 25.10 19.65
EPS (TTM) vs TTM 1 Yr. Ago 61.51 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate -13.77 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 7.83 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -- -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -762.28 -- --
EBITD - 5 Yr. Avg -3,432.75 -572.68 10.86
Operating Margin (TTM) -767.01 -717.10 4.64
Operating Margin - 5 Yr. Avg. -3,450.43 -594.00 6.26
Pre-Tax Margin (TTM) -789.28 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -3,320.66 -597.35 6.60
Net Profit Margin (TTM) -789.28 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -3,320.66 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 177,472 22,602,121 855,667,832
Net Income/Employee (TTM) -1,400,750 2,968,747 100,655,557
Receivable Turnover (TTM) 216.58 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.05 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.58 -1.05 10.98
Return on Assets - 5 Yr. Avg. -101.96 -0.57 12.37
Return on Investment (TTM) -45.27 1.66 14.43
Return on Investment - 5 Yr. Avg. -120.26 2.23 16.18
Return on Equity (TTM) -- 2.58 16.13
Return on Equity - 5 Yr. Avg. -220.88 3.13 17.47
  1 Year 3 Year 5 Year
Sales % 58.38 104.69 59.39
EPS (TTM) % -38.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ZIOPHARM Oncology Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 42.89%
# of Holders: 177
Total Shares Held: 60,886,948
3 Mo. Net Change: -654,151
# New Positions: 22
# Closed Positions: 14
# Increased Positions: 68
# Reduced Positions: 52
# Net Buyers: 16
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.